0000950170-24-026234.txt : 20240305 0000950170-24-026234.hdr.sgml : 20240305 20240305170751 ACCESSION NUMBER: 0000950170-24-026234 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huller Kelly CENTRAL INDEX KEY: 0001768417 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 24722116 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDOBON STATE: PA ZIP: 19403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 4 1 ownership.xml 4 X0508 4 2024-03-01 0001237831 GLOBUS MEDICAL INC GMED 0001768417 Huller Kelly VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 false true false false SVP, GC, Corporate Secretary true Class A Common Stock 2024-03-01 4 M false 7500 24.90 A 7500 D Class A Common Stock 2024-03-01 4 S false 4385 53.79 D 3115 D Class A Common Stock 2024-03-01 4 S false 3115 54.53 D 0 D Stock Option (Right to Buy Class A Common Stock) 24.90 2024-03-01 4 M false 7500 0 D 2024-03-04 Class A Common Stock 7500 0 D This sale was effected pursuant to a Rule 10b5-1 trading plan dated September 7, 2023 executed by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $53.36 - $54.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at a price range of $54.43 - $54.64, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the range set forth in footnote (3) to this Form 4. These options were granted on March 4, 2014 and are fully vested. /s/ Kelly G. Huller 2024-03-05